Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Current Liabilities (2020 - 2025)

Maravai Lifesciences Holdings has reported Total Current Liabilities over the past 6 years, most recently at $44.9 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $44.9 million for Q4 2025, down 21.16% from a year ago — trailing twelve months through Dec 2025 was $44.9 million (down 21.16% YoY), and the annual figure for FY2025 was $44.9 million, down 21.16%.
  • Total Current Liabilities for Q4 2025 was $44.9 million at Maravai Lifesciences Holdings, down from $61.6 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for MRVI hit a ceiling of $165.3 million in Q1 2021 and a floor of $44.9 million in Q4 2025.
  • Median Total Current Liabilities over the past 5 years was $82.5 million (2022), compared with a mean of $90.8 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 44.1% in 2023 and later tumbled 52.74% in 2024.
  • Maravai Lifesciences Holdings' Total Current Liabilities stood at $93.8 million in 2021, then rose by 17.45% to $110.1 million in 2022, then decreased by 20.59% to $87.5 million in 2023, then tumbled by 34.87% to $57.0 million in 2024, then fell by 21.16% to $44.9 million in 2025.
  • The last three reported values for Total Current Liabilities were $44.9 million (Q4 2025), $61.6 million (Q3 2025), and $69.7 million (Q2 2025) per Business Quant data.